Explore PMOS Research
Search 20,749 PMOS papers published between 2015 and 2025. Filter by research topic, country, year range, or co-investigated condition to find where the field is active — and where the gaps are.
Total citations
289,983
Peak year
2025(3,021 articles)
Avg citations / article
14
Publications per year
Topics
All research areas ⓘArticle mentionsA paper tagged with multiple topics counts once in each. The Overview uses fractional counting instead. See methodology.
Countries
All countries
Top journals
All filters
Top institutions
All filters
Where in the world is each topic being researched?
Toggle between Revealed Comparative Advantage (RCA), a specialisation index where values above 1.0 mean a country focuses on that topic more than average, and raw article counts.
| Hormones | Metabolic | Fertility | Epidemiol. | Pharma | Diagnos. | Genetics | Mental | Nutrition | Molecular | Inflamm. | Cell Bio | Lifestyle | Microbiome | Dermatol. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| China | 1.0 | 0.9 | 1.1 | 0.9 | 1.1 | 0.7 | 1.5 | 0.4 | 0.7 | 1.9 | 1.1 | 2.1 | 0.5 | 1.4 | 0.2 |
| United States | 1.0 | 1.1 | 1.0 | 1.3 | 0.8 | 1.1 | 0.9 | 1.4 | 0.6 | 0.6 | 0.7 | 0.6 | 1.0 | 0.6 | 1.3 |
| India | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 1.9 | 1.1 | 1.1 | 1.7 | 0.8 | 0.7 | 0.6 | 1.2 | 1.2 | 1.9 |
| Iran | 1.0 | 0.9 | 0.9 | 0.9 | 1.6 | 0.5 | 0.7 | 1.2 | 1.8 | 0.9 | 2.0 | 0.7 | 1.1 | 0.9 | 0.8 |
| Turkey | 1.2 | 1.2 | 0.8 | 0.4 | 0.4 | 1.4 | 0.5 | 1.0 | 1.0 | 0.6 | 1.7 | 0.5 | 0.4 | 1.3 | 1.4 |
| United Kingdom | 0.9 | 1.0 | 0.9 | 1.3 | 1.0 | 0.9 | 0.8 | 2.0 | 0.9 | 0.5 | 0.7 | 0.3 | 1.8 | 0.5 | 1.3 |
| Australia | 0.8 | 1.1 | 0.9 | 1.9 | 1.1 | 0.8 | 0.6 | 2.1 | 0.7 | 0.2 | 0.1 | 0.5 | 4.0 | 0.4 | 0.5 |
| Italy | 1.1 | 1.2 | 1.0 | 0.8 | 0.9 | 1.2 | 0.5 | 0.8 | 1.5 | 0.6 | 0.7 | 0.3 | 0.5 | 1.0 | 1.0 |
| Egypt | 1.0 | 0.8 | 1.9 | 0.4 | 1.7 | 0.8 | 0.4 | 0.6 | 1.1 | 0.6 | 1.0 | 0.5 | 0.3 | 0.3 | 2.2 |
| Poland | 1.3 | 1.4 | 0.5 | 0.6 | 0.4 | 0.8 | 0.6 | 1.2 | 0.8 | 0.6 | 1.2 | 0.4 | 1.1 | 1.7 | 1.6 |
Studies1,141–1,160 of 20,710
All studies
Review for "Efficacy of Liraglutide on Metabolic and Reproductive Outcomes in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis"
Data Sheet 1_Blood biochemical landscape and new insights into clinical decision-making for polycystic ovary syndrome in Chinese women: a prospective cohort study.docx
Supplemental Data for “Ovarian Insulin Signaling Is Intact Despite Systemic Insulin-Resistance in Androgen-Induced Polycystic Ovary Syndrome”
Animal models of polycystic ovary syndrome
Efficacy of Prostatic Specific Antigen as a Diagnostic Marker in Polycystic Ovary Syndrome and its Correlation with Lipid Profile
GnRH-a Pretreatment Doses and Frozen-Thawed Blastocyst Transfer Outcomes in PCOS Patients: A Retrospective Cohort Study.
Evaluation of some trace elements and their correlation with sex hormones in women with polycystic ovary syndrome
Efficacy & safety of sodium-glucose cotransporter-2 inhibitors in polycystic ovary syndrome: A meta-analysis with trial sequential analysis
Data Sheet 1_Exploration of the molecular mechanism of melatonin against polycystic ovary syndrome based on a network pharmacology approach and experimental validation.zip
Optimal total antral follicle count cutoff value for predicting biochemical hyperandrogenism in Korean women with polycystic ovary syndrome
Mendelian Randomization and Transcriptomics Analysis Reveal Potential Relationships Between Lipids, Immune Cells and PCOS.
The effects of metformin and sitagliptin for polycystic ovary syndrome treatment are enhanced by combining them
Adverse childhood experiences and risk of polycystic ovary syndrome among young adult females from Delhi NCR, India
Anti-androgenic compound Embelin ameliorates polycystic ovary syndrome by reversing the ovarian dysfunction and associated metabolic irregularities in 5α-DHT-induced PCOS rats
Polycystic ovary syndrome in relation to musculoskeletal health outcomes during midlife: a longitudinal cohort study
IMPACT OF INSULIN SENSITIZERS ON ANTI-MÜLLERIAN HORMONE IN POLYCYSTIC OVARY SYNDROME
P283 ATHEROSCLEROTIC CARDIOVASCULAR DISEASE, CARDIAC FUNCTION AND ATHEROGENIC DYSLIPIDEMIA IN YOUNG WOMEN WITH AND WITHOUT POLYCYSTIC OVARY SYNDROME: A STUDY ON THE NATURAL HISTORY OF CARDIOVASCULAR RISK
Homocysteine and Insulin Resistance among Women with Polycystic Ovary Syndrome
1518-P: Polycystic Ovary Syndrome (PCOS) and Arterial Stiffness (AS) in Youth with Type 1 Diabetes (T1D) in the SEARCH for Diabetes in Youth Cohort